Klinikum Altenburger Land Gmbh

Altenburg 04600

1 studies enrolling now · 8 studies all time

What they study most

Atrial Fibrillation, Cardiovascular Disease, Ischemic Stroke; Ischemic Attack, Transient, Myasthenia Gravis, Secondary Prevention, Spasticity as Sequela of Stroke, Stroke, Stroke, Acute

Studies at this site

• A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis — Completed
• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early